Maria Beatriz Madureira

Ms. Maria Beatriz Madureira

Londrina State University, Londrina, Paraná, Brazil
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
MMMaria Beatriz Madureira
Maria Beatriz Madureira
VCVirginia Marcia Concato
Virginia Marcia Concato
ECELLEN MAYARA SOUZA CRUZ
ELLEN MAYARA SOUZA CRUZ
JMJuliana Maria Bitencourt de Morais
Juliana Maria Bitencourt de Morais
FIFabricio Seidy Ribeiro Inoue
Fabricio Seidy Ribeiro Inoue
‪Wander R. Pavanelli‪Wander R. Pavanelli
‪Wander R. Pavanelli
Citrus (genus Citrus L.) fruits are essential sources of bioactive compounds with antioxidant properties, such as flavonoids. These polyphenolic compounds are divided into subclasses, in which flavanones are the most prominent. Among them, naringenin and hesperidin are emerging compounds with anticancer potential, especially for breast cancer (BC). Several mechanisms have been proposed, including the modulation of epigenetics, estrogen signaling, induction of cell death via regulation of apoptotic signaling pathways, and inhibition of tumor invasion and metastasis. However, this information is sparse in the literature and needs to be brought together to provide an overview of how naringenin and hesperidin can serve as therapeutic tools for drug development and as a successful co-adjuvant strategy against BC. This review detailed such mechanisms in this context and highlighted how naringenin and hesperidin could interfere in BC carcinogenesis and be helpful as potential alternative therapeutic sources for breast cancer treatment.